Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L MacMillan

Showing results (561-570 of 574) with videos related to

Pageof 58
Sort By:
Blood Advances|May 10, 2018
Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplantsAnita J Kumar, Soyoung Kim, Michael T Hemmer, et al.
Bone Marrow Transplantation|December 13, 2016
GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomesY-B Chen, T Wang, M T Hemmer, et al.
Frontiers in Immunology|November 15, 2023
Mediport use as an acceptable standard for CAR T cell infusionMaya Eylon, Snehit Prabhu, Samuel John, et al.
Pediatric Blood & Cancer|July 22, 2025
High Prevalence of Abnormal Baseline Lung Function in Pediatric and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Report from the TRANSPIRE StudyJane Koo, Richard Cooper, Stephanie L Edwards, et al.
Transplantation and Cellular Therapy|July 19, 2022
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD ProphylaxisRima M Saliba, Amin M Alousi, Joseph Pidala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 29, 2018
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic TransplantationSaurabh Chhabra, Ying Liu, Michael T Hemmer, et al.
Blood Advances|March 24, 2025
Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapyHannah Lust, Liora M Schultz, Soyang Kwon, et al.
Nature|November 30, 2022
Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancerAndrew L H Webster, Mathijs A Sanders, Krupa Patel, et al.
Blood Advances|May 5, 2019
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemiaRohtesh S Mehta, Shernan G Holtan, Tao Wang, et al.
Transplantation and Cellular Therapy|July 26, 2021
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular TherapyMohamed A Kharfan-Dabaja, Ambuj Kumar, Ernesto Ayala, et al.
Pageof 58

Showing results (561-570 of 574) with videos related to

Sort By:
Pageof 58
Blood Advances|May 10, 2018
Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplantsAnita J Kumar, Soyoung Kim, Michael T Hemmer, et al.
Bone Marrow Transplantation|December 13, 2016
GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomesY-B Chen, T Wang, M T Hemmer, et al.
Frontiers in Immunology|November 15, 2023
Mediport use as an acceptable standard for CAR T cell infusionMaya Eylon, Snehit Prabhu, Samuel John, et al.
Pediatric Blood & Cancer|July 22, 2025
High Prevalence of Abnormal Baseline Lung Function in Pediatric and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Report from the TRANSPIRE StudyJane Koo, Richard Cooper, Stephanie L Edwards, et al.
Transplantation and Cellular Therapy|July 19, 2022
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD ProphylaxisRima M Saliba, Amin M Alousi, Joseph Pidala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 29, 2018
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic TransplantationSaurabh Chhabra, Ying Liu, Michael T Hemmer, et al.
Blood Advances|March 24, 2025
Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapyHannah Lust, Liora M Schultz, Soyang Kwon, et al.
Nature|November 30, 2022
Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancerAndrew L H Webster, Mathijs A Sanders, Krupa Patel, et al.
Blood Advances|May 5, 2019
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemiaRohtesh S Mehta, Shernan G Holtan, Tao Wang, et al.
Transplantation and Cellular Therapy|July 26, 2021
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular TherapyMohamed A Kharfan-Dabaja, Ambuj Kumar, Ernesto Ayala, et al.
Pageof 58